Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

OnCore Login
Login to Oncore Network

Login to Oncore Network

Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

HCRN-ESO17-325

A Phase II Study Evaluating Safety and Efficacy of Niraparib in Patients With Previously Treated Homologous Recombination (HR) Defective or Loss of Heterozygosity (LOH) High Metastatic Esophageal/Gastroesophageal Junction/Proximal Gastric Adenocarcinoma

Learn more:

Abstracts/Posters/Presentations:

  • H Mamdani, R Mehta, C Fountzilas, M Radovich, S Perkins, SI Jalal. A phase II study evaluating safety and efficacy of niraparib in patients with previously treated homologous recombination (HR) defective or loss of heterozygosity (LOH) high-metastatic esophageal/GEJ/proximal gastric adenocarcinoma. Presented as Trials In Progress Poster at the 2020 Gastrointestinal Cancers Symposium, January 23, 2020. J Clin Oncol 38, 2020 (suppl 4; abstr TPS472). See abstract.